
membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
05-05-25 23:59
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
24/02/25 | OSE IMMUNOTHERAPEUTICS | Achat | 500 E | 6.93 | 5.97 | -14.04% | -70 | ![]() |
0 |
19/02/25 | MEDINCELL SA | Achat | 400 E | 13.46 | 15.23 | 12.94% | 52 | ![]() |
0 |
19/02/25 | VALNEVA SE | Vente | 1 000 E | 3.62 | 2.92 | 17.32% | 173 | ![]() |
0 |
18/02/25 | VALNEVA SE | Vente | 1 000 E | 3.60 | 2.92 | 16.85% | 169 | ![]() |
0 |
19/12/24 | EUROAPI | Vente | 1 000 E | 2.80 | 2.76 | -2.13% | -21 | ![]() |
0 |
18/12/24 | COGELEC SA | Achat | 500 E | 15.10 | 21.70 | 43.46% | 217 | ![]() |
0 |
17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 21.70 | 39.76% | 199 | ![]() |
0 |
17/12/24 | COGELEC SA | Achat | 500 E | 15.50 | 21.70 | 39.76% | 199 | ![]() |
0 |
12/11/24 | VALNEVA SE | Vente | 1 000 E | 2.30 | 2.92 | -31.17% | -312 | ![]() |
0 |
06/11/24 | MEDINCELL SA | Achat | 400 E | 15.22 | 15.23 | -0.13% | -1 | ![]() |
0 |
28/10/24 | VALBIOTIS | Achat | 400 E | 1.27 | 1.11 | -12.94% | -52 | ![]() |
0 |
28/10/24 | VALBIOTIS | Achat | 400 E | 1.34 | 1.11 | -17.50% | -70 | ![]() |
0 |
22/10/24 | ADOCIA | Achat | 400 E | 8.51 | 4.91 | -42.52% | -170 | ![]() |
0 |
21/10/24 | ADOCIA | Achat | 400 E | 7.65 | 4.91 | -36.05% | -144 | ![]() |
0 |
02/10/24 | ADVICENNE | Achat | 500 E | 2.25 | 1.79 | -20.62% | -103 | ![]() |
0 |
02/10/24 | ADVICENNE | Achat | 400 E | 2.29 | 1.79 | -22.01% | -88 | ![]() |
0 |
01/10/24 | ADVICENNE | Achat | 400 E | 1.62 | 1.79 | 10.28% | 41 | ![]() |
0 |
30/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 8.11 | 5.97 | -26.56% | -106 | ![]() |
0 |
23/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.41 | 5.97 | -19.61% | -59 | ![]() |
0 |
19/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.76 | 5.97 | -23.24% | -93 | ![]() |
0 |
17/09/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 7.24 | 5.97 | -17.72% | -71 | ![]() |
0 |
22/08/24 | VALBIOTIS | Achat | 400 E | 1.79 | 1.11 | -38.26% | -153 | ![]() |
0 |
05/06/24 | VALBIOTIS | Achat | 400 E | 2.31 | 1.11 | -52.18% | -209 | ![]() |
0 |
29/05/24 | ADVICENNE | Achat | 400 E | 2.47 | 1.79 | -27.70% | -111 | ![]() |
0 |
29/05/24 | ADVICENNE | Achat | 400 E | 2.54 | 1.79 | -29.70% | -119 | ![]() |
24 |
10/05/24 | MEDINCELL SA | Achat | 400 E | 14.96 | 15.23 | 1.60% | 6 | ![]() |
0 |
10/05/24 | MEDINCELL SA | Achat | 400 E | 15.10 | 15.23 | 0.66% | 3 | ![]() |
0 |
08/04/24 | ADOCIA | Achat | 400 E | 10.38 | 4.91 | -52.89% | -212 | ![]() |
0 |
25/03/24 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 4.57 | 5.97 | 30.40% | 122 | ![]() |
0 |
21/03/24 | REWORLD MEDIA | Achat | 400 E | 3.21 | 1.64 | -49.06% | -196 | ![]() |
0 |
18/12/23 | INNATE PHARMA | Achat | 400 E | 2.34 | 2.01 | -14.29% | -57 | ![]() |
0 |
08/11/23 | VALBIOTIS | Achat | 400 E | 6.46 | 1.11 | -82.97% | -332 | ![]() |
0 |
19/09/23 | ADVICENNE | Achat | 500 E | 2.39 | 1.79 | -25.28% | -126 | ![]() |
0 |
18/09/23 | ADVICENNE | Achat | 400 E | 2.42 | 1.79 | -26.21% | -105 | ![]() |
0 |
14/06/23 | VALBIOTIS | Achat | 400 E | 4.32 | 1.11 | -74.48% | -298 | ![]() |
0 |
13/06/23 | INNATE PHARMA | Achat | 400 E | 3.20 | 2.01 | -37.35% | -149 | ![]() |
0 |
23/09/21 | OSE IMMUNOTHERAPEUTICS | Achat | 400 E | 11.16 | 5.97 | -46.66% | -187 | ![]() |
7 |
23/09/21 | INNATE PHARMA | Achat | 400 E | 6.15 | 2.01 | -67.45% | -270 | ![]() |
7 |
21/09/21 | INNATE PHARMA | Achat | 400 E | 5.92 | 2.01 | -66.18% | -265 | ![]() |
7 |
15/04/21 | VALBIOTIS | Achat | 400 E | 7.92 | 1.11 | -86.12% | -344 | ![]() |
7 |
14/04/21 | VALBIOTIS | Achat | 400 E | 8.19 | 1.11 | -86.58% | -346 | ![]() |
5 |
31/03/21 | ADVICENNE | Achat | 400 E | 12.00 | 1.79 | -85.20% | -341 | ![]() |
7 |
16/03/21 | VALBIOTIS | Achat | 400 E | 7.84 | 1.11 | -85.98% | -344 | ![]() |
7 |
10/02/21 | VALBIOTIS | Achat | 300 E | 7.56 | 1.11 | -85.46% | -256 | ![]() |
7 |
04/02/21 | VALBIOTIS | Achat | 300 E | 6.98 | 1.11 | -84.24% | -253 | ![]() |
4 |
21/01/21 | VALBIOTIS | Achat | 300 E | 6.78 | 1.11 | -83.77% | -251 | ![]() |
8 |
27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 2.01 | -55.18% | -166 | ![]() |
8 |
12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 2.01 | -47.53% | -143 | ![]() |
7 |
11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 2.01 | -47.94% | -144 | ![]() |
4 |
10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 2.01 | -40.87% | -123 | ![]() |
7 |
Enregistrements 1 à 50 sur 61 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
12/03/20 | YMAGIS | Achat | 300 E | 2.03 | 1.00 | -50.89% | -153 | ![]() |
8 |
12/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.87 | 1.20 | -35.99% | -108 | ![]() |
3 |
12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.68 | 3.40 | -7.80% | -23 | ![]() |
7 |
12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.80 | 3.40 | -10.72% | -32 | ![]() |
9 |
12/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.89 | 3.40 | -12.78% | -38 | ![]() |
8 |
12/03/20 | IT LINK | Achat | 600 E | 15.60 | 10.20 | -34.78% | -209 | ![]() |
20 |
12/03/20 | IT LINK | Achat | 600 E | 15.92 | 10.20 | -36.09% | -217 | ![]() |
13 |
12/03/20 | ACTIA GROUP | Achat | 300 E | 3.92 | 2.60 | -33.84% | -102 | ![]() |
5 |
12/03/20 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.61 | 0.97 | -39.91% | -120 | ![]() |
2 |
12/03/20 | ESKER | Achat | 300 E | 83.50 | 90.90 | 8.65% | 26 | ![]() |
11 |
12/03/20 | INNATE PHARMA | Achat | 200 E | 8.40 | 4.97 | -40.99% | -82 | ![]() |
7 |
12/03/20 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 472.20 | 418.80 | -11.50% | -35 | ![]() |
8 |
12/03/20 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 475.80 | 418.80 | -12.17% | -37 | ![]() |
29 |
12/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 200 E | 7.75 | 3.97 | -48.93% | -98 | ![]() |
4 |
11/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 4.41 | 4.65 | 5.24% | 105 | ![]() |
2 |
11/03/20 | MEDIAN TECHNOLOGIES | Achat | 300 E | 1.83 | 1.44 | -21.49% | -64 | ![]() |
3 |
09/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.69 | 4.23 | 14.35% | 287 | ![]() |
2 |
09/03/20 | ADVICENNE | Achat | 300 E | 10.50 | 8.40 | -20.18% | -61 | ![]() |
10 |
09/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 6.95 | 4.47 | -35.85% | -108 | ![]() |
4 |
09/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 7.05 | 4.47 | -36.76% | -110 | ![]() |
5 |
09/03/20 | ADOCIA | Achat | 300 E | 19.50 | 7.53 | -61.52% | -185 | ![]() |
3 |
09/03/20 | ADOCIA | Achat | 300 E | 12.84 | 7.53 | -41.51% | -125 | ![]() |
2 |
09/03/20 | ADOCIA | Achat | 300 E | 16.80 | 7.53 | -55.32% | -166 | ![]() |
10 |
09/03/20 | THERADIAG | Achat | 300 E | 1.06 | 1.32 | 24.30% | 73 | ![]() |
5 |
06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.82 | 3.81 | -0.46% | -9 | ![]() |
2 |
06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.68 | 3.81 | 3.33% | 67 | ![]() |
2 |
06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.68 | 3.78 | 2.51% | 50 | ![]() |
2 |
06/03/20 | EUROFINS SCIENTIFIC SE | Vente | 2 000 E | 505.50 | 450.80 | 10.56% | 211 | ![]() |
3 |
06/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.64 | 3.78 | 3.55% | 71 | ![]() |
3 |
06/03/20 | INNATE PHARMA | Achat | 300 E | 6.07 | 6.28 | 3.26% | 10 | ![]() |
4 |
06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 3.78 | 3.75 | -0.99% | -3 | ![]() |
7 |
06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.04 | 3.75 | -7.37% | -22 | ![]() |
6 |
06/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.06 | 3.75 | -7.83% | -23 | ![]() |
8 |
05/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.55 | 3.39 | -4.77% | -95 | ![]() |
3 |
05/03/20 | EUROFINS SCIENTIFIC SE | Vente | 2 000 E | 513.00 | 492.80 | 3.71% | 74 | ![]() |
4 |
04/03/20 | AMU-BX4 AMUNDI CAC40 DAY INV 1 | Achat | 2 000 E | 3.72 | 3.48 | -6.65% | -133 | ![]() |
3 |
03/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 6.05 | 5.43 | -10.44% | -31 | ![]() |
2 |
03/03/20 | ADOCIA | Achat | 2 000 E | 12.76 | 9.10 | -29.34% | -587 | ![]() |
2 |
02/03/20 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 300 E | 9.92 | 5.29 | -46.83% | -140 | ![]() |
13 |
02/03/20 | INNATE PHARMA | Achat | 600 E | 9.52 | 6.50 | -31.89% | -191 | ![]() |
12 |
02/03/20 | ACTIA GROUP | Achat | 300 E | 4.32 | 3.19 | -26.33% | -79 | ![]() |
4 |
02/03/20 | ACTIA GROUP | Achat | 300 E | 3.94 | 3.19 | -19.22% | -58 | ![]() |
4 |
02/03/20 | OSE IMMUNOTHERAPEUTICS | Achat | 200 E | 3.87 | 3.51 | -9.49% | -19 | ![]() |
4 |
02/03/20 | ADOCIA | Achat | 300 E | 17.26 | 9.13 | -47.26% | -142 | ![]() |
4 |
02/03/20 | ADOCIA | Achat | 300 E | 16.60 | 9.13 | -45.16% | -135 | ![]() |
10 |
02/03/20 | ADOCIA | Achat | 300 E | 13.08 | 9.13 | -30.37% | -91 | ![]() |
4 |
02/03/20 | ADOCIA | Achat | 300 E | 17.60 | 9.13 | -48.28% | -145 | ![]() |
4 |
02/03/20 | ADOCIA | Achat | 300 E | 10.88 | 9.13 | -16.27% | -49 | ![]() |
2 |
02/03/20 | EUROFINS SCIENTIFIC SE | Achat | 300 E | 450.20 | 462.20 | 2.46% | 7 | ![]() |
7 |
02/03/20 | MAUNA KEA TECHNOLOGIES | Achat | 300 E | 1.40 | 1.24 | -11.62% | -35 | ![]() |
1 |
Enregistrements 701 à 750 sur 1154 |